CI
CRVS icon

Cowen Inc’s Corvus Pharmaceuticals CRVS Stock Holding History

Cowen Inc’s Portfolio CRVS Stock Details CRVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$2.15M Sell
576,231
-7,592
-1% -$29.7K 0.16% 105
2019
Q1 		$2.35M Sell
583,823
-75,196
-11% -$317K 0.25% 71
2018
Q4 		$2.42M Buy
659,019
+70,313
+12% +$479K 0.27% 88
2018
Q3 		$5.05M Buy
588,706
+54,309
+10% +$543K 0.46% 62
2018
Q2 		$5.87M Buy
+534,397
New +$5.97M 0.25% 72

Other funds holding CRVS

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Cowen Inc's CRVS Position: Q2 2019 in Review

Cowen Inc reduced its Corvus Pharmaceuticals (CRVS) stake by 1.3% in Q2 2019, selling an estimated $29.7K and leaving 576,231 shares worth $2.15M. The position accounts for 0.16% of the portfolio, ranked #105.

Cowen Inc first reported a position in CRVS in Q2 2018 and has held it in 5 quarters since. The position peaked at $5.87M in Q2 2018. 45 funds tracked by Wall St. Rank hold CRVS as of Q2 2019.

  • Cowen Inc held 576,231 shares of Corvus Pharmaceuticals worth $2.15M as of Q2 2019.
  • Cowen Inc sold 7,592 Corvus Pharmaceuticals shares in Q2 2019, an estimated $29.7K.
  • Corvus Pharmaceuticals made up 0.16% of Cowen Inc's portfolio in Q2 2019, its #105 holding.
  • Cowen Inc first reported a position in Corvus Pharmaceuticals in Q2 2018 and has held it in 5 quarters since.
  • Cowen Inc's Corvus Pharmaceuticals position peaked at $5.87M in Q2 2018.
  • 45 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.